Christian Uhrich

Christian Uhrich is an experienced investment professional specializing in biotechnology investments, currently serving as Investment Director and Head of Strategy at M Ventures since September 2019. Uhrich holds several board positions, including Board Observer roles at LabGenius, Iktos, DNA Script, and Scipio Bioscience, as well as being a Member of the Board of Directors for companies such as Indi Molecular, CellFE, Lightcast Discovery, and Astraveus. Notably, Uhrich contributed to Riffyn's integration into Siemens Life Science offerings after its acquisition in 2022. Educational credentials include an MBA from Mannheim Business School and a degree in Computer Science and Business Administration from Baden-Wuerttemberg Cooperative State University.